The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with Paclitaxel (P) in patients (pts) with 1st- to 3rd-line metastatic HER2-negative breast cancer (BC).
 
Monica M. Mita
Consulting or Advisory Role - Genentech (I)
 
Carlos Becerra
Consulting or Advisory Role - Novocure
Speakers' Bureau - Celgene; Lilly; Taiho Pharmaceutical
 
Donald A. Richards
Consulting or Advisory Role - Boehringer Ingelheim; Insys Therapeutics; IntegraGen; Lilly; Pharmacyclics
Speakers' Bureau - Celgene
 
Alain C. Mita
Speakers' Bureau - Genentech
 
Elena Shagisultanova
No Relationships to Disclose
 
Cynthia R. C. Osborne
No Relationships to Disclose
 
Joyce O'Shaughnessy
No Relationships to Disclose
 
Chun Zhang
Employment - Oncomed
Stock and Other Ownership Interests - Oncomed
Patents, Royalties, Other Intellectual Property - OncoMed
 
Randall Henner
Employment - OncoMed
Leadership - Clarus Ventures (I); Cleave Biosciences (I); comentis (I); Forty Seven (I); Imago Pharma (I)
Stock and Other Ownership Interests - OncoMed
 
Ann M. Kapoun
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - co-author of patents filed at OncoMed (Inst)
Travel, Accommodations, Expenses - OncoMed
 
Lu Xu
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Jakob Dupont
Employment - Oncomed
Leadership - Oncomed
Stock and Other Ownership Interests - Oncomed
Patents, Royalties, Other Intellectual Property - Oncomed
 
Rainer Karl Brachmann
Employment - Gilead Sciences (I); OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - Gilead Sciences (I); OncoMed
 
Azeez Farooki
Consulting or Advisory Role - Akrimax Pharmaceuticals; Alexion Pharmaceuticals; Amgen; Bayer/Onyx; Celgene; NPS Pharmaceuticals; OncoMed
Speakers' Bureau - Abbott/AbbVie; Merck
 
Jennifer Robinson Diamond
Research Funding - Casi Pharmaceuticals